Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 31

Sort by

Sort Order Select

Journal Articles

Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network report

Stuart E. Lacy, Sharon L. Barrans, Philip A. Beer, Daniel Painter, Alexandra G. Smith, Eve Roman, Susanna L. Cooke, Camilo Ruiz, Paul Glover, Suzan J. L. Van Hoppe, Nichola Webster, Peter J. Campbell, Reuben M. Tooze, Russell Patmore, Cathy Burton, Simon Crouch, Daniel J. Hodson

Blood (2020) 135 (20): 1759–1771.

https://doi.org/10.1182/blood.2019003535

Published: 2020

Includes: Supplemental data

Journal Articles

Does Life-Expectancy in Patients with Diffuse Large B-Cell Lymphoma Return to Normal? Findings from a UK-Based Population-Based Study

Russell Patmore, FRCPath, Alexandra Smith, PhD, Han-I Wang, PhD, Maxine Lamb, PhD, Debra Howell, PhD, Cathy Burton, Eve Roman, PhD

Blood (2018) 132 (Supplement 1): 1695.

https://doi.org/10.1182/blood-2018-99-115277

Published: 2018

Journal Articles

Mantle Cell Lymphoma Management and Outcome in the U.K's Population-Based Haematological Malignancy Research Network

Russell Patmore, MRCP FRCPath, Alexandra Smith, PhD, Simon Appleton, Debra Howell, PhD, Roderick J. Johnson, MD, Cathy H Burton, Eve Roman, PhD

Blood (2016) 128 (22): 1112.

https://doi.org/10.1182/blood.V128.22.1112.1112

Published: 2016

Journal Articles

Novel Targeted Therapies and Their Impact on Survival from Multiple Myeloma (MM) and Chronic Lymphocytic Leukaemia (CLL) in the Real World

Alexandra G Smith, PhD, Timothy Bagguley, MSc, Eve Roman, PhD, Andy C Rawstron, James R Bailey, MA MBBS MRCP, Debra Howell, PhD, John Ashcroft, MD MBBChir, PhD MRCP, MA, FRCPath, Burton Cathy, Gordon Cook, MD PhD, Russell Patmore, MRCP FRCPath

Blood (2016) 128 (22): 3546.

https://doi.org/10.1182/blood.V128.22.3546.3546

Published: 2016

Journal Articles

Validation of Plasma Cell Immunophenotype As a Biomarker to Identify High-Risk Smoldering Myeloma

Andy C Rawstron, BSc, PhD, Alex Smith, Ruth Mary de Tute, PhD FRCPath, Dan Painter, Eve Roman, Roger G Owen, MD

Blood (2016) 128 (22): 4451.

https://doi.org/10.1182/blood.V128.22.4451.4451

Published: 2016

Journal Articles

Similarity Search Methods As an Alternative to Sub-Type Characterisation in Aggressive Lymphomas

Chulin Sha, PhD, Sharon Barrans, PhD, Andrew Jack, Cathy H Burton, Alexandra Smith, PhD, Eve Roman, Dan Painter, Simon Crouch, PhD, Reuben M Tooze, PhD FRCP, Matthew Care, PhD, David R Westhead, PhD

Blood (2016) 128 (22): 3052.

https://doi.org/10.1182/blood.V128.22.3052.3052

Published: 2016

Journal Articles

Poor Outcomes in HIV Negative and HIV Positive Patients with Plasmablastic Lymphoma (PBL) in a Population Based Patient Study

Niamh Appleby, Ruth Cullen, Dan Painter, Alexandra Smith, Eve Roman, Sharon Barrans, PhD, Sheila J.M. O'Connor, Catherine H Burton, Andrew S Jack, Roger G Owen, Reuben M Tooze, PhD FRCP

Blood (2015) 126 (23): 3924.

https://doi.org/10.1182/blood.V126.23.3924.3924

Published: 2015

Journal Articles

Predicting Time to Treatment in Follicular Lymphoma Using Population-Based Data

Russell Patmore, MRCP FRCPath, Alexandra Smith, Burton Cathy, Eve Roman, Simon Crouch, PhD

Blood (2015) 126 (23): 3912.

https://doi.org/10.1182/blood.V126.23.3912.3912

Published: 2015

Journal Articles

Social Inequality Is An Important Risk Factor For Death From Chronic Myeloid Leukaemia: Findings From a UK Population-Based Cohort

Alexandra Smith, PhD, Eve Roman, PhD, Daniel Painter, BSc, Debra Howell, PhD, Graeme Smith, MD, Paul Evans, Russell Patmore, MD, Andrew Jack, PhD

Blood (2013) 122 (21): 4036.

https://doi.org/10.1182/blood.V122.21.4036.4036

Published: 2013

Journal Articles

Bone Marrow Staging For Lymphoma: A Re-Evaluation Of Clinical Utility

Andrew Jack, PhD, Daniel Painter, BSc, Alexandra Smith, PhD, Eve Roman, PhD, Ruth M de Tute, MSc, Russell Patmore, MD

Blood (2013) 122 (21): 4278.

https://doi.org/10.1182/blood.V122.21.4278.4278

Published: 2013

Journal Articles

Skeletal-Related Events In Myeloma: A Population-Based Study

John Ashcroft, MD, MBBChir, PhD, MRCP, MA, FRCPath, Bagguley Timothy, MSc, Alexandra Smith, PhD, Han-I Wang, PhD, Debra Howell, PhD, Hazem A Sayala, MBChB, MRCP, Gordon Cook, MD, PhD, Andrew Jack, PhD, Russell Patmore, MD, Eve Roman, PhD

Blood (2013) 122 (21): 3158.

https://doi.org/10.1182/blood.V122.21.3158.3158

Published: 2013

Journal Articles

A Meta-Analysis Of Hodgkin Lymphoma Reveals 19p13.3 (TCF3) As a Novel Susceptibility Loc

Wendy Cozen, D.O., M.P.H., Dalin Li, M.D., Ph.D., Maria Timofeeva, Ph.D., Arjan Diepstra, MD PhD, Dennis Hazelett, Ph.D., Manon Delahaye-Sourdeix, M.S., Christopher K. Edlund, M.S., Klaus Rostgaard, Ph.D., David J. Van Den Berg, Ph.D., Lude Franke, Ph.D., Karin Eckstrom Smedby, M.D., Ph.D., Sally L. Glaser, Ph.D., Harm-Jam Westra, Ph.D., Leslie L. Robison, PhD, Thomas M. Mack, M.D., M.P.H., Herve Ghesquieres, MD, PhD, Amie E. Hwang, Ph.D., M.P.H., Alexandra Nieters, Ph.D., Silvia de Sanjosé, M.D., Ph.D., Victoria K. Cortessis, Ph.D., Tracy Lightfoot, Nikolaus Becker, M.D., Ph.D., Marc Maynadie, MD, PhD, Lenka Foretova, Ph.D., Eve Roman, Ph.D., Yolanda Benavente, Ph.D., Bharat N. Nathwani, M.D., Bengt Glimelius, M.D., Ph.D., Anthony Staines, M.D., Ph.D., Paolo Boffetta, M.D., M.P.H., Brian K Link, MD, L. A. Kiemeney, Ph.D., Stephen M Ansell, M.D.Ph.D., Smita Bhatia, Ph.D., Louise C Strong, Ph.D., Pilar Galan, M.D., Lars Vatten, M.D., Ph.D., Thomas M Habermann, MD, Eric J. Duell, Ph.D., M.S., Annette Lake, M.S., Rianne Veenstra, Lydia Visser, PhD, Kevin Urayama, Ph.D., Dorothy Montgomery, Valerie Gaborieau, Lawrence Weiss, M.D, Graham Byrnes, Ph.D., Mark Lathrop, PhD, Hans-Olov Adami, M.D., Ph.D., Mads Melbye, MD, DMSc, James R Cerhan, MD, PhD, Alice Gallagher, M.D., G. Malcolm Taylor, MD, Susan L Slager, PhD, Paul Brennan, Ph.D., David V. Conti, Ph.D., Gerhard Coetzee, Ph.D., Kenan Onel, MD, PhD, Ruth F. Jarrett, M.D., Ph.D., Henrik Hjalgrim, M.D., Ph.D., Anke Van Den Berg, PhD, James D. McKay, Ph.D.

Blood (2013) 122 (21): 626.

https://doi.org/10.1182/blood.V122.21.626.626

Published: 2013

Journal Articles

Development Of A Cross Platform, 2-Way Gene Expression Classifier To Distinguish Burkitt Lymphoma From DLBCL, and Assessment Of The Potential Impact Of Its Use In Treatment Decision Making

Sharon Barrans, PhD, Sha Chulin, Alex Smith, Simon Crouch, MA PhD, Lisa Worrillow, PhD, Eve Roman, PhD, David Westhead, PhD, Andrew Jack, PhD

Blood (2013) 122 (21): 74.

https://doi.org/10.1182/blood.V122.21.74.74

Published: 2013

Journal Articles

The Prognosis Of Transformed Follicular Lymphoma Is Determined By Prior Exposure To Chemotherapy

Andrew Jack, PhD, Alexandra Smith, PhD, Ruth de Tute, Daniel Painter, BSc, Eve Roman, PhD, Russell Patmore, MD

Blood (2013) 122 (21): 78.

https://doi.org/10.1182/blood.V122.21.78.78

Published: 2013

Journal Articles

Variation at 10p12.2 and 10p14 influences risk of childhood B-cell acute lymphoblastic leukemia and phenotype

Blood (2013) 122 (19): 3298–3307.

https://doi.org/10.1182/blood-2013-03-491316

Published: 2013

Includes: Supplemental data

Journal Articles

A Unified Prognostic Model for Myelodysplastic Syndrome and Acute Myeloid Leukaemia Based on Flow Cytometric Blast Count

Alexandra Smith, BSc PhD, Simon Crouch, MA PhD, Dan Painter, Eve Roman, Matt Cullen, Fiona Bennett, Catherine Cargo, MB, MRCP, Andrew Jack, PhD, MB

Blood (2011) 118 (21): 1736.

https://doi.org/10.1182/blood.V118.21.1736.1736

Published: 2011

Journal Articles

Identifying Phenotypically and Clinically Distinct Entities within the Spectrum of Marginal Zone Lymphoma and Lymphoplasmacytic Lymphoma/Waldenstrom Macroglobulinemia

Ruth M de Tute, Eve Roman, Andrew Jack, PhD, MB, Roger G Owen, MD, Andy Rawstron, PhD

Blood (2011) 118 (21): 2652.

https://doi.org/10.1182/blood.V118.21.2652.2652

Published: 2011

Journal Articles

MHC variation and risk of childhood B-cell precursor acute lymphoblastic leukemia

Fay J. Hosking, Stephen Leslie, Alexander Dilthey, Loukas Moutsianas, Yufei Wang, Sara E. Dobbins, Elli Papaemmanuil, Eamonn Sheridan, Sally E. Kinsey, Tracy Lightfoot, Eve Roman, Julie A. E. Irving, James M. Allan, Malcolm Taylor, Mel Greaves, Gilean McVean, Richard S. Houlston

Blood (2011) 117 (5): 1633–1640.

https://doi.org/10.1182/blood-2010-08-301598

Published: 2011

Includes: Supplemental data

Journal Articles

Haematological Reference Ranges for Neonates with Down Syndrome In the UK: A Report From the Children with Down's Syndrome Study

Rebecca James, Tom Johnston, Tracy Lightfoot, Dan Painter, Pat Ansell, Eve Roman, Sally Kinsey

Blood (2010) 116 (21): 79.

https://doi.org/10.1182/blood.V116.21.79.79

Published: 2010

Journal Articles

A Comprehensive Report of Blood Cell Morphology for Neonates with Down's Syndrome In the UK: A Report From the Children with Down's Syndrome Study

Rebecca James, Tom Johnston, Tracy Lightfoot, Dan Painter, Pat Ansell, Eve Roman, Sally Kinsey

Blood (2010) 116 (21): 80.

https://doi.org/10.1182/blood.V116.21.80.80

Published: 2010

NARROW

Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network report

Does Life-Expectancy in Patients with Diffuse Large B-Cell Lymphoma Return to Normal? Findings from a UK-Based Population-Based Study

Mantle Cell Lymphoma Management and Outcome in the U.K's Population-Based Haematological Malignancy Research Network

Novel Targeted Therapies and Their Impact on Survival from Multiple Myeloma (MM) and Chronic Lymphocytic Leukaemia (CLL) in the Real World

Validation of Plasma Cell Immunophenotype As a Biomarker to Identify High-Risk Smoldering Myeloma

Similarity Search Methods As an Alternative to Sub-Type Characterisation in Aggressive Lymphomas

Poor Outcomes in HIV Negative and HIV Positive Patients with Plasmablastic Lymphoma (PBL) in a Population Based Patient Study

Predicting Time to Treatment in Follicular Lymphoma Using Population-Based Data

Social Inequality Is An Important Risk Factor For Death From Chronic Myeloid Leukaemia: Findings From a UK Population-Based Cohort

Bone Marrow Staging For Lymphoma: A Re-Evaluation Of Clinical Utility

Skeletal-Related Events In Myeloma: A Population-Based Study

A Meta-Analysis Of Hodgkin Lymphoma Reveals 19p13.3 (TCF3) As a Novel Susceptibility Loc

Development Of A Cross Platform, 2-Way Gene Expression Classifier To Distinguish Burkitt Lymphoma From DLBCL, and Assessment Of The Potential Impact Of Its Use In Treatment Decision Making

The Prognosis Of Transformed Follicular Lymphoma Is Determined By Prior Exposure To Chemotherapy

Variation at 10p12.2 and 10p14 influences risk of childhood B-cell acute lymphoblastic leukemia and phenotype

A Unified Prognostic Model for Myelodysplastic Syndrome and Acute Myeloid Leukaemia Based on Flow Cytometric Blast Count

Identifying Phenotypically and Clinically Distinct Entities within the Spectrum of Marginal Zone Lymphoma and Lymphoplasmacytic Lymphoma/Waldenstrom Macroglobulinemia

MHC variation and risk of childhood B-cell precursor acute lymphoblastic leukemia

Haematological Reference Ranges for Neonates with Down Syndrome In the UK: A Report From the Children with Down's Syndrome Study

A Comprehensive Report of Blood Cell Morphology for Neonates with Down's Syndrome In the UK: A Report From the Children with Down's Syndrome Study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only